Corticosterone and Adrenocorticotrophic Hormone Secretion Is Recovered after Immune Challenge or Acute Restraint Stress in Sepsis Survivor Animals

dos Santos-Junior N.N.a· da Costa L.H.A.a· Catalão C.H.R.a· Alves Rocha M.J.b

Author affiliations

aDepartment of Neurosciences and Behavioral Sciences, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
bDepartment of Psychology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil

Log in to MyKarger to check if you already have access to this content.

Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.

Save over 20% compared to the individual article price.

Learn more

Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more

Subcription rates

Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview

Abstract of Research Article

Received: July 24, 2021
Accepted: October 28, 2021
Published online: February 01, 2022

Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 0

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: https://www.karger.com/NIM

Abstract

Background: Clinical and experimental studies report a dysregulation of hypothalamus-pituitary-adrenal (HPA) axis during sepsis that causes impairment in hormone secretion in the late phase contributing for the pathophysiology of the disease. However, it is unclear whether this alteration persists even after the disease remission. Methods: We evaluated the effect of an immune challenge or restraint stress on the hormone secretion of HPA axis in sepsis survivor rats. Sepsis was induced by cecal ligation-puncture (CLP) surgery. Naive or animals that survive 5 or 10 days after CLP were submitted to lipopolysaccharide (LPS) injection or restraint stress. After 60 min, blood was collected for plasma nitrate, cytokines, adrenocorticotropic hormone (ACTH), and corticosterone (CORT) and brain for synaptophysin and hypothalamic cytokines. Results: Five days survivor animals showed increased plasma nitrate (p < 0.001) and interleukin (IL)-1β levels (p < 0.05) that were abolished in the 10 days survivors. In the hypothalamus of both survivors, the reverse was seen with IL-6 increased (p < 0.01), while IL-1β did not show any alteration. Synaptophysin expression was reduced in both survivors and did not change after any stimuli. Only the LPS administration increased plasma and/or inflammatory mediators levels in both groups (survivors and naive) being apparently lower in the survivors. There was no difference in the increased secretion pattern of ACTH and CORT observed in the naive and sepsis survivor animals submitted to immune challenge or restraint stress. Conclusion: We conclude that the HPA axis is already recovered soon after 5 days of sepsis induction responding with normal secretion of ACTH and CORT when required.

© 2022 S. Karger AG, Basel

References Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016 Feb;315(8):801–10. Sharshar T, Blanchard A, Paillard M, Raphael JC, Gajdos P, Annane D. Circulating vasopressin levels in septic shock. Crit Care Med. 2003 Jun;31(6):1752–8. Benjamim CF, Canetti C, Cunha FQ, Kunkel SL, Peters-Golden M. Opposing and hierarchical roles of leukotrienes in local innate immune versus vascular responses in a model of sepsis. J Immunol. 2005 Feb;174(3):1616–20. Sriskandan S, Altmann DM. The immunology of sepsis. J Pathol. 2008 Jan;214(2):211–23. Martins TF, Sorgi CA, Faccioli LH, Rocha MJ. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. J Neuroimmunol. 2011 Sep;238(1–2):52–7. Wahab F, Atika B, Oliveira-Pelegrin GR, Rocha MJ. Recent advances in the understanding of sepsis-induced alterations in the neuroendocrine system. Endocr Metab Immune Disord Drug Targets. 2013 Dec;13(4):335–47. Wahab F, Santos-Junior NN, de Almeida Rodrigues RP, Costa LHA, Catalão CHR, Rocha MJA. Interleukin-1 receptor antagonist decreases hypothalamic oxidative stress during experimental sepsis. Mol Neurobiol. 2016 Aug;53(6):3992–8. Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017 07;39(5):517–28. Corrêa PB, Pancoto JA, de Oliveira-Pelegrin GR, Cárnio EC, Rocha MJ. Participation of iNOS-derived NO in hypothalamic activation and vasopressin release during polymicrobial sepsis. J Neuroimmunol. 2007 Feb;183(1–2):17–25. Pancoto JA, Corrêa PB, Oliveira-Pelegrin GR, Rocha MJ. Autonomic dysfunction in experimental sepsis induced by cecal ligation and puncture. Auton Neurosci. 2008 Feb;138(1–2):57–63. dos Santos JF, de Oliveira-Pelegrin GR, Athayde LA, da Rocha MJ. An inhibitor of leukotriene synthesis affects vasopressin secretion following osmotic stimulus in rats. Regul Pept. 2012 Nov;179(1–3):6–9. Gheorghiţă V, Barbu AE, Gheorghiu ML, Căruntu FA. Endocrine dysfunction in sepsis: a beneficial or deleterious host response? Germs. 2015 Mar;5(1):17–25. da Costa LHA, Júnior NNDS, Catalão CHR, Sharshar T, Chrétien F, da Rocha MJA. Vasopressin impairment during sepsis is associated with hypothalamic intrinsic apoptotic pathway and microglial activation. Mol Neurobiol. 2017 Sep;54(7):5526–33. Molnár L, Fülesdi B, Németh N, Molnár C. Sepsis-associated encephalopathy: a review of literature. Neurol India. 2018 Mar–Apr;66(2):352–61. Landry DW, Levin HR, Gallant EM, Ashton RC, Seo S, DʼAlessandro D, et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation. 1997 Mar;95(5):1122–5. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000 Feb;283(8):1038–45. Carlson DE, Chiu WC, Scalea TM. Cecal ligation and puncture in rats interrupts the circadian rhythms of corticosterone and adrenocortical responsiveness to adrenocorticotrophic hormone. Crit Care Med. 2006 Apr;34(4):1178–84. Polito A, Sonneville R, Guidoux C, Barrett L, Viltart O, Mattot V, et al. Changes in CRH and ACTH synthesis during experimental and human septic shock. PLoS One. 2011;6(11):e25905. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med. 1998 Apr;26(4):645–50. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004 Aug;329(7464):480. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med. 2004 Jul;141(1):47–56. Santos-Junior NN, Costa LHA, Catalão CHR, Kanashiro A, Sharshar T, Rocha MJA. Impairment of osmotic challenge-induced neurohypophyseal hormones secretion in sepsis survivor rats. Pituitary. 2017 Oct;20(5):515–21. Santos-Junior NN, Catalão CH, Costa LH, Rossignoli BB, Dos-Santos RC, Malvar D, et al. Alterations in hypothalamic synaptophysin and death markers may be associated with vasopressin impairment in sepsis survivor rats. J Neuroendocrinol. 2018 May:e12604. Santos-Junior NN, Catalão CHR, Costa LHA, Souza AO, Mota CMD, Alberici LC, et al. Experimental sepsis induces sustained inflammation and acetylcholinesterase activity impairment in the hypothalamus. J Neuroimmunol. 2018 Nov;324:143–8. Rothwell PM, Udwadia ZF, Lawler PG. Cortisol response to corticotropin and survival in septic shock. Lancet. 1991 Mar 9;337(8741):582–3. Soni A, Pepper GM, Wyrwinski PM, Ramirez NE, Simon R, Pina T, et al. Adrenal insufficiency occurring during septic shock: incidence, outcome, and relationship to peripheral cytokine levels. Am J Med. 1995 Mar;98(3):266–71. Flierl MA, Rittirsch D, Weckbach S, Huber-Lang M, Ipaktchi K, Ward PA, et al. Disturbances of the hypothalamic-pituitary-adrenal axis and plasma electrolytes during experimental sepsis. Ann Intensive Care. 2011 Dec;1:53. Saia RS, Oliveira-Pelegrin GR, da Silva ME, Aguila FA, Antunes-Rodrigues J, Rocha MJ, et al. Neonatal endotoxin exposure changes neuroendocrine, cardiovascular function and mortality during polymicrobial sepsis in adult rats. Regul Pept. 2011 Aug 8;169(1–3):21–30. Lai F, Zhou G, Mai S, Qin X, Liu W, Zhang Y, et al. Sini decoction improves adrenal function and the short-term outcome of septic rats through downregulation of adrenal toll-like receptor 4 expression. Evid Based Complement Alternat Med. 2018;2018:5186158. de Carvalho Borges B, Carnio EC, Elias LL, Antunes-Rodrigues J, Branco LG, da Rocha MJ. Lesion of the anteroventral third ventricle (AV3V) reduces hypothalamic activation and hypophyseal hormone secretion induced by lipopolysaccharide in rats. Brain Res. 2006 Oct;1115(1):83–91. Laguna-Abreu MT, Margatho L, Germano CM, Antunes-Rodrigues J, Elias LL, de Castro M. The effect of adrenalectomy on fos expression in vasopressinergic and oxytocinergic neurons in response to stress in the rat. Stress. 2007 Nov;10(4):332–41. Catalão CHR, Santos-Júnior NN, da Costa LHA, Souza AO, Alberici LC, Rocha MJA. Brain oxidative stress during experimental sepsis is attenuated by simvastatin administration. Mol Neurobiol. 2017 Nov;54(9):7008–18. Nemzek JA, Xiao HY, Minard AE, Bolgos GL, Remick DG. Humane endpoints in shock research. Shock. 2004 Jan;21(1):17–25. Bazhanova ED, Zhukov DA, Danilova OA. Differences in the reaction of old and young rats to immobilization stress. Zh Evol Biokhim Fiziol. 1994 Jul–Aug;30(4):541–6. Vahl TP, Ulrich-Lai YM, Ostrander MM, Dolgas CM, Elfers EE, Seeley RJ, et al. Comparative analysis of ACTH and corticosterone sampling methods in rats. Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E823–8. Jennewein C, Tran N, Kanczkowski W, Heerdegen L, Kantharajah A, Dröse S, et al. Mortality of septic mice strongly correlates with adrenal gland inflammation. Crit Care Med. 2016 Apr;44(4):e190–9. Thrasher TN, Keil LC, Ramsay DJ. Lesions of the organum vasculosum of the lamina terminalis (OVLT) attenuate osmotically-induced drinking and vasopressin secretion in the dog. Endocrinology. 1982 May;110(5):1837–9. Iovino M, Steardo L. Vasopressin release to central and peripheral angiotensin II in rats with lesions of the subfornical organ. Brain Res. 1984 Nov;322(2):365–8. Stare J, Siami S, Trudel E, Prager-Khoutorsky M, Sharshar T, Bourque CW. Effects of peritoneal sepsis on rat central osmoregulatory neurons mediating thirst and vasopressin release. J Neurosci. 2015 Sep;35(35):12188–97. Barichello T, Martins MR, Reinke A, Constantino LS, Machado RA, Valvassori SS, et al. Behavioral deficits in sepsis-surviving rats induced by cecal ligation and perforation. Braz J Med Biol Res. 2007 Jun;40(6):831–7. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010 Oct;304(16):1787–94. Westphal GA, Vieira KD, Orzechowski R, Kaefer KM, Zaclikevis VR, Mastroeni MF. Analysis of quality of life following hospital discharge among survivors of severe sepsis and septic shock. Rev Panam Salud Publica. 2012 Jun;31(6):499–505. Steckert AV, Comim CM, Mina F, Mendonça BP, Dominguini D, Ferreira GK, et al. Late brain alterations in sepsis-survivor rats. Synapse. 2013 Nov;67(11):786–93. Moraes CA, Santos G, de Sampaio e Spohr TC, DʼAvila JC, Lima FR, Benjamim CF, et al. Activated microglia-induced deficits in excitatory synapses through IL-1β: implications for cognitive impairment in sepsis. Mol Neurobiol. 2015 Aug;52(4):871–86. Catalão CHR, Santos-Junior NN, da Costa LHA, Souza AO, Cárnio EC, Sebollela A, et al. Simvastatin prevents long-term cognitive deficits in sepsis survivor rats by reducing neuroinflammation and neurodegeneration. Neurotox Res. 2020;38(1):653–63. Bienkowski MS, Rinaman L. Immune challenge activates neural inputs to the ventrolateral bed nucleus of the stria terminalis. Physiol Behav. 2011 Aug;104(2):257–65. Diorio D, Viau V, Meaney MJ. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J Neurosci. 1993 Sep;13(9):3839–47. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci. 2007 Feb;27(8):2025–34. Choi DC, Furay AR, Evanson NK, Ulrich-Lai YM, Nguyen MM, Ostrander MM, et al. The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pituitary-adrenocortical axis responsiveness to acute and chronic stress. Psychoneuroendocrinology. 2008 Jun;33(5):659–69. Ajmone-Cat MA, Nicolini A, Minghetti L. Prolonged exposure of microglia to lipopolysaccharide modifies the intracellular signaling pathways and selectively promotes prostaglandin E2 synthesis. J Neurochem. 2003 Dec;87(5):1193–203. Vyas D, Javadi P, Dipasco PJ, Buchman TG, Hotchkiss RS, Coopersmith CM. Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R1048–53. Pallás Beneyto LA, Rodríguez Luis O, Saiz Sánchez C, Coltell O, Bautista Rentero D, Miguel Bayarri V. Prognostic value of interleukin 6 for death of patients with sepsis. Med Clin. 2016 10;147(7):281–6. Chaudhry N, Duggal AK. Sepsis associated encephalopathy. Adv Med. 2014;2014:762320. Wiedenmann B, Franke WW. Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell. 1985 Jul;41(3):1017–28. Wiedenmann B, Franke WW, Kuhn C, Moll R, Gould VE. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. Proc Natl Acad Sci U S A. 1986 May;83(10):3500–4. Monneret G, Venet F, Kullberg BJ, Netea MG. ICU-acquired immunosuppression and the risk for secondary fungal infections. Med Mycol. 2011 Apr;49(Suppl 1):S17–23. Markwart R, Condotta SA, Requardt RP, Borken F, Schubert K, Weigel C, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of naïve T-cells but no enduring cell-autonomous defects in T-cell function. PLoS One. 2014;9(12):e115094. Article / Publication Details

First-Page Preview

Abstract of Research Article

Received: July 24, 2021
Accepted: October 28, 2021
Published online: February 01, 2022

Number of Print Pages: 11
Number of Figures: 6
Number of Tables: 0

ISSN: 1021-7401 (Print)
eISSN: 1423-0216 (Online)

For additional information: https://www.karger.com/NIM

Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

留言 (0)

沒有登入
gif